Literature DB >> 16314020

Combined treatment of olanzapine and mirtazapine in anorexia nervosa associated with major depression.

Tzong-Shi Wang1, Yuan-Hwa Chou, I-Shin Shiah.   

Abstract

Several studies have shown that olanzapine is effective in weight restoration and maintenance for patients with anorexia nervosa (AN). However, major depression is a very common comorbid psychiatric disorder associated with AN. Additional antidepressant therapy may be required for treating anorexic patients with major depression. The authors present a case of AN associated with major depression, who responded well to the combination treatment of olanzapine and mirtazapine. A 27-year-old Taiwanese woman was admitted because of severe weight loss, poor nutrition, amenorrhea, major depression, and starvation complications including hematological dyscrasis, electrolytes and endocrine imbalance, and sinus bradycardia. In additional to nutritional and medical treatments, the patient was given olanzapine 10 mg/day and mirtazapine 30 mg/day. She took the combined medications for six months. Meanwhile she received cognitive behavior therapy and family therapy. With these treatments, the patient's depression was in remission, her body weight was increased from 24 to 38 kg, and her body mass index was increased from 9.8 to 15.5. Our case suggests that the combined treatment of olanzapine and mirtazapine can be used in the treatment of AN associated with major depression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16314020     DOI: 10.1016/j.pnpbp.2005.10.004

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  5 in total

Review 1.  Antipsychotic agents in the treatment of anorexia nervosa: neuropsychopharmacologic rationale and evidence from controlled trials.

Authors:  Timothy D Brewerton
Journal:  Curr Psychiatry Rep       Date:  2012-08       Impact factor: 5.285

2.  Differential weight restoration on olanzapine versus fluoxetine in identical twins with anorexia nervosa.

Authors:  Vikas Duvvuri; Taya Cromley; Megan Klabunde; Kerri Boutelle; Walter H Kaye
Journal:  Int J Eat Disord       Date:  2011-02-22       Impact factor: 4.861

3.  Mirtazapine in the treatment of adolescent anorexia nervosa. Case-control study.

Authors:  Michal Hrdlicka; Irena Beranova; Renata Zamecnikova; Tomas Urbanek
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-04       Impact factor: 4.785

4.  Comparative study of rate of weight loss among premorbid and healthy restrictive eaters.

Authors:  S Kovalchik
Journal:  Eat Weight Disord       Date:  2008-12       Impact factor: 3.008

Review 5.  Role of antidepressants in the treatment of adults with anorexia nervosa.

Authors:  Marketa Marvanova; Kirstin Gramith
Journal:  Ment Health Clin       Date:  2018-04-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.